U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H16ClNO2S.ClH
Molecular Weight 358.283
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOPIDOGREL HYDROCHLORIDE

SMILES

Cl.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl

InChI

InChIKey=XIHVAFJSGWDBGA-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.ClH/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;/h2-5,7,9,15H,6,8,10H2,1H3;1H/t15-;/m0./s1

HIDE SMILES / InChI
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C16H16ClNO2S
Molecular Weight 321.822
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:57:17 UTC 2023
Edited
by admin
on Fri Dec 15 17:57:17 UTC 2023
Record UNII
426O7XWS6Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOPIDOGREL HYDROCHLORIDE
EMA EPAR   WHO-DD  
Common Name English
CLOPIDOGREL TEVA GENERICS B.V.
Brand Name English
CLOPIDOGREL HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
CLOPIDOGREL-TAD
Brand Name English
CLOPIDOGREL QUALIMED
Brand Name English
CLOPIDOGREL HYDROCHLORIDE [EMA EPAR]
Common Name English
CLOPIDOGREL-DURA
Brand Name English
Clopidogrel hydrochloride [WHO-DD]
Common Name English
CLOPIDOGREL TEVA PHARMA
Brand Name English
CLOPIDOGREL-HCS
Brand Name English
CLOPIDOGREL-KRKA
Brand Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, HYDROCHLORIDE, (S)-
Common Name English
CLOPIDOGREL MYLAN
Brand Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS CLOPIDOGREL KRKA (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-TAD (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-HCS (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL KRKA D.D. (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL KRKA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TAD (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-HCS (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL DURA (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL QUALIMED (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL QUALIMED (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-DURA (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL MYLAN (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL KRKA D.D. (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-KRKA (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL KRKA D.D. (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL QUALIMED (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL DURA (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
NCI_THESAURUS C80483
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA (AUTHORIZED: AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL-HCS (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL MYLAN (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TAD (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL HCS (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL MYLAN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
Code System Code Type Description
DRUG BANK
DBSALT002594
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
SMS_ID
100000115888
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
CAS
120202-65-5
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
PUBCHEM
9798860
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
FDA UNII
426O7XWS6Y
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
NCI_THESAURUS
C96893
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
EVMPD
SUB30779
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
EPA CompTox
DTXSID40152734
Created by admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
PRIMARY
Related Record Type Details
Structure of CLOPIDOGREL
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of Methyl α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of CLOPIDOGREL CARBOXYLIC ACID
IMPURITY -> PARENT
Structure of Methyl (αS)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of CLOPIDOGREL, (R)-
IMPURITY -> PARENT
Structure of 2-(2-CHLOROPHENYL)-2-(6,7-DIHYDROTHIENO(3,2-C)PYRIDIN-5(4H)-YL)ACETAMIDE, (±)-
IMPURITY -> PARENT
Structure of Methyl (αR)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of (1R)-1-(2-CHLOROPHENYL)-2-METHOXY-2-OXOETHYL (.ALPHA.S)-.ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE
IMPURITY -> PARENT
Structure of METHYL (2S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETATE
IMPURITY -> PARENT
Related Record Type Details
Structure of CLOPIDOGREL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966